Stocks / NASDAQ / Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc.

Our Opinion

Assertio Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“Cosyntropin represents the foundation of our new orphan specialty business and offers a low-cost alternative in a market dominated by one high-cost, animal-derived product that generates annual sales of more than $1 billion.” Read the following article

Company Description

Company Website: https://www.assertiotx.com